Please login to the form below

Not currently logged in
Email:
Password:

Antibiotics among 7 new drugs backed by EMA

EU flagThe Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

CHMP thumbs up for Novo's obesity drug Saxenda

Novo Nordisk headquartersDiabetes drug liraglutide on course for new indication in EU

FDA panel backs new antifungal Cresemba

FDA headquarters White OakBasilea/Astellas drug tipped to become a $500m product

NICE heart attack recommendation for Xarelto

Bayer Xarelto rivaroxaban 2.5Bayer drug on course for another blood clot indication in England and Wales

Havas Group acquires German comms agency Bird & Schulte

Freiburg-based firm will now operate as Havas Life Bird & Schulte

UCB submits brivaracetam for use in epilepsy

UCBFiles drug in both the US and EU

Genzyme's oral Gaucher drug cleared in Europe

genzyme officesCerdelga now available to adults with type 1 Gaucher disease

AZ files gout drug lesinurad in Europe

AstraZeneca AZ headquarters London UKAcquired drug as part of its takeover of Ardea Biosciences in 2012

Pharma can learn to invent like an entrepreneur

Why pharma firms don’t always have to behave like corporations

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptiv Solutions

Aptiv Solutions is a global development services company focused on enhancing clinical trial decision-making, efficiency and productivity for pharmaceutical, biotech...

Latest intelligence

How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....
Is obesity really a problem in Brazil?
Obesity is on the rise in low- and middle-income countries, particularly in urban settings...